The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Lymphadenectomy for the management of endometrial cancer
Open accessAbstract
BACKGROUND: This is an update of a previous Cochrane review published in Issue 1, 2010 and updated in Issue 9, 2015. The role of lymphadenectomy in surgical management of endometrial cancer remains controversial. Lymph node metastases can be found in approximately 10% of women who before surgery are thought to have cancer confined to the womb. Removal of all pelvic and para-aortic lymph nodes (lymphadenectomy) at initial surgery has been widely advocated, and pelvic and para-aortic lymphadenectomy remains part of the FIGO (International Federation of Gynaecology and Obstetrics) staging system for endometrial cancer. This recommendation is based on data from studies that suggested improvement in survival following pelvic and para-aortic lymphadenectomy. However, these studies were not randomised controlled trials (RCTs), and treatment of pelvic lymph nodes may not confer a direct therapeutic benefit, other than allocating women to poorer prognosis groups. Furthermore, the Cochrane review and meta-analysis of RCTs of routine adjuvant radiotherapy to treat possible lymph node metastases in women with early-stage endometrial cancer found no survival advantage. Surgical removal of pelvic and para-aortic lymph nodes has serious potential short-term and long-term sequelae. Therefore, it is important to investigate the clinical value of this treatment. OBJECTIVES: To evaluate the effectiveness and safety of lymphadenectomy for the management of endometrial cancer. SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and Embase to June 2009 for the original review, updated the search to June 2015 for the last updated version and further extended the search to March 2017 for this version of the review. We also searched registers of clinical trials, abstracts of scientific meetings, and reference lists of included studies, and we contacted experts in the field. SELECTION CRITERIA: RCTs and quasi-RCTs that compared lymphadenectomy versus no lymphadenectomy in adult women diagnosed with endometrial cancer. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data and assessed risk of bias. Hazard ratios (HRs) for overall and progression-free survival and risk ratios (RRs) comparing adverse events in women who received lymphadenectomy versus those with no lymphadenectomy were pooled in random-effects meta-analyses. We assessed the quality of the evidence using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach. MAIN RESULTS: 978 unique references were identified via the search strategy. All but 50 were excluded by title and abstract screening. Three RCTs met the inclusion criteria; for one small RCT, data were insufficient for inclusion in the meta-analysis. The two RCTs included in the analysis randomly assigned 1945 women, reported HRs for survival adjusted for prognostic factors and based on 1851 women and had an overall low risk of bias, as they satisfied four of the assessment criteria. The third study had an overall unclear risk of bias, as information provided was not adequate concerning random sequence generation, allocation concealment, blinding, or completeness of outcome reporting.Results of the meta-analysis remained unchanged from the previous versions of this review and indicated no differences in overall and recurrence-free survival between women who underwent lymphadenectomy and those who did not undergo lymphadenectomy (pooled hazard ratio (HR) 1.07, 95% confidence interval (CI) 0.81 to 1.43; HR 1.23, 95% CI 0.96 to 1.58 for overall and recurrence-free survival, respectively) (1851 participants, two studies; moderate-quality evidence).We found no difference in risk of direct surgical morbidity between women who underwent lymphadenectomy and those who did not undergo lymphadenectomy. However, women who underwent lymphadenectomy had a significantly higher risk of surgery-related systemic morbidity and lymphoedema/lymphocyst formation than those who did not undergo lymphadenectomy (RR 3.72, 95% CI 1.04 to 13.27; RR 8.39, 95% CI 4.06 to 17.33 for risk of surgery-related systemic morbidity and lymphoedema/lymphocyst formation, respectively) (1922 participants, two studies; high-quality evidence). AUTHORS' CONCLUSIONS: This review found no evidence that lymphadenectomy decreases risk of death or disease recurrence compared with no lymphadenectomy in women with presumed stage I disease. Evidence on serious adverse events suggests that women who undergo lymphadenectomy are more likely to experience surgery-related systemic morbidity or lymphoedema/lymphocyst formation. Currently, no RCT evidence shows the impact of lymphadenectomy in women with higher-stage disease and in those at high risk of disease recurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
Pecorelli, S. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.02.012 · Cited by 2,881
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Bucher, H. C., Guyatt, G. H., Griffith, L. E., & Walter, S. D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00049-8 · Cited by 2,052
Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study
Creasman, W. T., Morrow, C. P., Bundy, B. N., Homesley, H. D., Graham, J. E., & Heller, P. B. (1987) · Cancer · doi:10.1002/1097-0142(19901015)60:8+<2035::aid-cncr2820601515>3.0.co;2-8 · Cited by 1,963
(2009) · The Lancet · doi:10.1016/s0140-6736(08)61766-3 · Cited by 1,801
Panici, P. B., Basile, S., Maneschi, F., Lissoni, A. A., Signorelli, M., Scambia, G., Angioli, R., Tateo, S., Mangili, G., Katsaros, D., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn397 · Cited by 1,544
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Meader, N., King, K., Llewellyn, A., Norman, G., Brown, J., Rodgers, M., Moe-Byrne, T., Higgins, J. P., Sowden, A., & Stewart, G. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-82 · Cited by 610
Revised FIGO staging for gynaecological cancer
Shepherd, J. H. (1989) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1989.tb03341.x · Cited by 585
Kilgore, L. C., Partridge, E. E., Alvarez, R. D., Austin, J. M., Shingleton, H. M., Noojin, F., & Conner, W. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1005 · Cited by 527
Assessing and presenting summaries of evidence in Cochrane Reviews
Langendam, M. W., Akl, E. A., Dahm, P., Glasziou, P., Guyatt, G., & Schünemann, H. J. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-81 · Cited by 282
Cancer trends in England and Wales
Dickinson, H. O. (2000) · BMJ · doi:10.1136/bmj.320.7239.884 · Cited by 209
Sentinel lymph node biopsy in endometrial cancer: Meta-analysis of 26 studies
Kang, S., Yoo, H. J., Hwang, J. H., Lim, M.-C., Seo, S.-S., & Park, S.-Y. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.08.034 · Cited by 186
Wallace, B. C., Noel-Storr, A., Marshall, I. J., Cohen, A. M., Smalheiser, N. R., & Thomas, J. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocx053 · Cited by 186
Lymphadenectomy for the management of endometrial cancer
May, K., Bryant, A., Dickinson, H. O., Kehoe, S. T., & Morrison, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007585.pub2 · Cited by 181
Self-citationTrovik, J., Wik, E., Werner, H. M. J., Krakstad, C., Helland, H., Vandenput, I., Njølstad, T. S., Stefansson, I. M., Marcickiewicz, J., Tingulstad, S., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.016 · Cited by 158
Rossi, E. C., Jackson, A. L., Ivanova, A., & Boggess, J. F. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182a616f6 · Cited by 127
Lymphadenectomy for the management of endometrial cancer
Frost, J., Webster, K. E., Bryant, A., & Morrison, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007585.pub3 · Cited by 102
Self-citationBody size, adult BMI gain and endometrial cancer risk: the multiethnic cohort
Park, S. L., Goodman, M. T., Zhang, Z., Kolonel, L. N., Henderson, B. E., & Setiawan, V. W. (2009) · International Journal of Cancer · doi:10.1002/ijc.24718 · Cited by 93
Crosbie, E. J., Roberts, C., Qian, W., Swart, A. M., Kitchener, H. C., & Renehan, A. G. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.003 · Cited by 89
Panici, P. B., Basile, S., Salerno, M. G., Donato, V. D., Marchetti, C., Perniola, G., Palagiano, A., Perutelli, A., Maneschi, F., Lissoni, A. A., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.12.025 · Cited by 87
van de Poll-Franse, L. V., Pijnenborg, J. M. A., Boll, D., Vos, M. D., van den Berg, H., Lybeert, M. L. M., Winter, K. D., & Kruitwagen, R. F. P. M. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.06.007 · Cited by 51
Catechol-O-Methyltransferase and Cytochrome P-450 1B1 Polymorphisms and Endometrial Cancer Risk
Teng, Y., He, C., Zuo, X., et al. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182849e0d · Cited by 19
Cited by
Makker, V., MacKay, H., Ray-Coquard, I., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00324-8 · Cited by 674
Ballester, M., Dubernard, G., Lécuru, F., Heitz, D., Mathevet, P., Marret, H., Querleu, D., Golfier, F., Leblanc, E., Rouzier, R., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70070-5 · Cited by 574
Janda, M., Gebski, V., Davies, L. C., Forder, P., Brand, A., Hogg, R., Jobling, T. W., Land, R., Manolitsas, T., Nascimento, M., et al. (2017) · JAMA · doi:10.1001/jama.2017.2068 · Cited by 447
Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis
Bodurtha Smith, A. J., Fader, A. N., & Tanner, E. J. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.11.1033 · Cited by 330
Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology
Nougaret, S., Horta, M., Sala, E., Lakhman, Y., Thomassin-Naggara, I., Kido, A., Masselli, G., Bharwani, N., Sadowski, E., Ertmer, A., et al. (2019) · European Radiology · doi:10.1007/s00330-018-5515-y · Cited by 283
Metadata
- Authors
- Frost, J. A., Webster, K. E., Bryant, A., & Morrison, J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-10-02
- Volume
- 2017
- Issue
- 10
- Pages
- CD007585-CD007585
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2141396229
- Cited by
- 430
- References
- 36
- FWCI
- 34.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.